Greens-Based Crossover Trial to Improve Epigenetic Aging in Adults

Running, not enrolling · Not applicable

Conditions studied: Aging

In brief

The primary purpose of this study is to assess changes in epigenetic markers of aging and physiological parameters in overweight older adults consuming a mixed greens-based supplement over a 30-day period in a randomized crossover design.

Key facts

Study ID

NCT06537232

Run by

Auburn University

People needed

20

Starts

2024-09-04

Expected to finish

2025-03-01

Last updated by the study team

2025-01-08

Who can join

Age: 50 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men and women of any ethnicity (women must be postmenopausal)
• Body Mass Index > 30 kg/m\^2
• Low habitual dark green leafy vegetable consumption
• Willing to adhere to study protocol and measures
• Willing to communicate via smartphone technology
• Able to read, write and speak English

You may not qualify if…

• Overt cardiometabolic diseases such heart attack, stroke, diabetes, insulin resistance and non-alcoholic fatty liver disease, etc.
• Diagnosis of a transient ischemic attack in the 6 months prior to screening
• Diagnosis of cancer within 5 years prior to screening, except for cutaneous basal cell or squamous cell cancer resolved by excision
• Food allergies

Where it is running

• Auburn University — Auburn, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.